Company Valuation: Singapore Institute of Advanced Medicine Holdings Ltd.

Data adjusted to current consolidation scope
Fiscal Period: June 2024 2025 2026
Market Cap 1 105.9 30.8 51.72
Change - -70.91% 67.94%
Enterprise Value (EV) 1 148.7 85.63 97.6
Change - -42.43% 13.98%
P/E -2.22x -1.13x -1.5x
PBR 1.29x 0.55x 0.98x
PEG -0x 0x 0.1x
Capitalization / Revenue 6.36x 1.96x 3.29x
EV / Revenue 8.94x 5.45x 6.21x
EV / EBITDA -13.3x -6.73x -7.99x
EV / EBIT -7.17x -3.95x -4.96x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.0455 -0.0257 -0.0201
Distribution rate - - -
Net sales 1 16.65 15.71 15.72
EBITDA 1 -11.22 -12.72 -12.21
EBIT 1 -20.73 -21.7 -19.69
Net income 1 -37.45 -27.05 -23.9
Net Debt 1 42.89 54.83 45.88
Reference price 2 0.1010 0.0290 0.0300
Nbr of stocks (in thousands) 1,048,099 1,062,021 1,724,092
Announcement Date 12/11/24 10/12/25 10/14/26
1SGD in Million2SGD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 31.03M
13.15x0.4x8.38x2.95% 115B
15.63x1.89x9.41x0.66% 98.85B
-288.65x20.15x-340.61x-.--% 59.72B
14.48x1.57x9.5x2.44% 30.06B
26.78x2.33x13.22x0.8% 29.34B
24.39x2.71x13.74x1.31% 27.71B
7.51x1.45x6.4x-.--% 21.75B
29.58x5.3x21.64x2.36% 19.96B
30.38x2.86x12.88x1.46% 17.09B
Average -14.08x 4.29x -27.27x 1.33% 41.99B
Weighted average by Cap. -26.21x 4.32x -39.53x 1.45%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Singapore Institute of Advanced Medicine Holdings Ltd.

Historical PBR trend

Valuation ratios - PBR - Singapore Institute of Advanced Medicine Holdings Ltd.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Singapore Institute of Advanced Medicine Holdings Ltd.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Singapore Institute of Advanced Medicine Holdings Ltd.

  1. Stock Market
  2. Stocks
  3. 9G2 Stock
  4. Valuation Singapore Institute of Advanced Medicine Holdings Ltd.